KALARIS THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
KALARIS THERAPEUTICS, INC. (KLRS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.01M, a 49.80% decline year-over-year.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $34.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$357.00K, a 148.70% decline year-over-year.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$2.04M.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.81M, a 325.40% decline from fiscal 2024.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $803.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$5.61M, a 285.40% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.03M, a 144.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.04M 10-Q · filed 2026-08-11 | $685.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.36M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-12 | -$323.00K derived: sum of 2 quarters · filed 2026-05-12 | -$2.36M derived: sum of 3 quarters · filed 2026-05-12 | -$356.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.40M derived: sum of 2 quarters · filed 2026-03-17 | -$390.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.81M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$33.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.45M 10-Q · filed 2025-11-12 | -$720.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $588.00K 10-Q · filed 2026-08-11 | $1.32M derived: sum of 3 quarters · filed 2026-08-11 | $988.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$1.42M 10-Q · filed 2026-05-12 | -$687.00K derived: sum of 2 quarters · filed 2026-05-12 | -$1.02M derived: sum of 3 quarters · filed 2026-05-12 | -$1.01M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $400.00K derived: sum of 2 quarters · filed 2026-03-17 | $408.00K derived: sum of 3 quarters · filed 2026-03-17 | $803.00K 10-K · filed 2026-03-17 | -$3.23M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$325.00K derived: sum of 2 quarters · filed 2025-11-12 | $70.00K 10-Q · filed 2025-11-12 | -$2.86M 10-Q · filed 2024-11-12 | -$2.91M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $403.00K 10-Q · filed 2025-08-13 | -$3.26M 10-Q · filed 2024-08-09 | -$2.58M derived: sum of 3 quarters · filed 2025-08-13 | -$2.35M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $395.00K 10-Q · filed 2025-05-14 | -$2.71M 10-Q · filed 2024-05-13 | -$2.59M derived: sum of 2 quarters · filed 2025-05-14 | -$2.36M derived: sum of 3 quarters · filed 2025-05-14 | -$5.55M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$2.76M derived: sum of 2 quarters · filed 2025-03-07 | -$5.95M derived: sum of 3 quarters · filed 2025-03-07 | -$5.61M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.97M derived: sum of 2 quarters · filed 2024-11-12 | -$2.63M 10-Q · filed 2024-11-12 | -$1.47M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$2.86M 10-Q · filed 2024-08-09 | -$1.69M derived: sum of 3 quarters · filed 2024-08-09 | $1.59M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $333.00K 10-Q · filed 2024-05-13 | $1.50M derived: sum of 2 quarters · filed 2024-05-13 | $4.78M derived: sum of 3 quarters · filed 2024-05-13 | $3.65M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $4.45M derived: sum of 2 quarters · filed 2024-03-15 | $3.31M derived: sum of 3 quarters · filed 2024-03-15 | $3.03M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.15M derived: sum of 2 quarters · filed 2023-11-02 | $1.86M 10-Q · filed 2023-11-02 | $1.16M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.42M 10-Q · filed 2023-08-03 | -$2.13M derived: sum of 3 quarters · filed 2023-08-03 | $1.46M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$284.00K 10-Q · filed 2023-05-04 | -$986.00K derived: sum of 2 quarters · filed 2023-05-04 | $2.60M derived: sum of 3 quarters · filed 2023-05-04 | $2.69M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $2.88M derived: sum of 2 quarters · filed 2023-02-15 | $2.98M derived: sum of 3 quarters · filed 2023-02-15 | $1.24M 10-K · filed 2023-02-15 | ||||
| 2021-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.68M derived: sum of 2 quarters · filed 2022-11-03 | $1.94M 10-Q · filed 2022-11-03 | $1.27M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.64M 10-Q · filed 2022-08-04 | -$2.31M derived: sum of 3 quarters · filed 2022-08-04 | $480.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$1.74M 10-Q · filed 2022-05-05 | -$2.41M derived: sum of 2 quarters · filed 2022-05-05 | $383.00K derived: sum of 3 quarters · filed 2022-05-05 | $1.85M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $2.12M derived: sum of 2 quarters · filed 2022-02-10 | $3.58M derived: sum of 3 quarters · filed 2022-02-10 | $3.87M 10-K · filed 2022-02-10 | ||||
| 2020-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $4.26M derived: sum of 2 quarters · filed 2021-11-05 | $4.54M 10-Q · filed 2021-11-05 | $4.86M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.75M 10-Q · filed 2021-08-06 | $2.07M derived: sum of 3 quarters · filed 2021-08-06 | $1.99M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $284.00K 10-Q · filed 2021-05-06 | $603.00K derived: sum of 2 quarters · filed 2021-05-06 | $526.00K derived: sum of 3 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $242.00K derived: sum of 2 quarters · filed 2021-02-12 | $620.00K 10-K · filed 2021-02-12 | |||||
| 2019-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $301.00K 10-Q · filed 2020-11-10 | ||||||
| 2019-06-30 | $378.00K 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |